MIR6890: A Potential Drug Target for Cancer (G102465536)
MIR6890: A Potential Drug Target for Cancer
MIR6890 (hsa-miR-6890-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study.
MIR6890 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs have been shown to have a wide range of functions, including regulating cell growth, cell cycle progression, and apoptosis.
One of the reasons why MIR6890 has gained so much attention is its unique expression pattern. MIR6890 is highly expressed in most tissues and cells, but its expression level is highly variable between different cell types and tissues. This variability makes it an ideal candidate for a drug target, as targeting a protein that is expressed in a wide range of cells could be difficult.
In addition, MIR6890 has been shown to play a role in various diseases, including cancer. Studies have shown that MIR6890 is highly expressed in many types of cancer, including breast, ovarian, and colorectal cancer. Additionally, MIR6890 has been shown to be involved in the regulation of cell cycle progression and apoptosis, which are important processes in cancer development.
Furthermore, MIR6890 has been shown to have a positive correlation with cancer outcomes. Studies have shown that higher MIR6890 expression is associated with poor prognosis in cancer patients. This suggests that targeting MIR6890 could be a promising strategy for cancer treatment.
In conclusion, MIR6890 is a promising drug target or biomarker for various diseases, including cancer. Its unique expression pattern and involvement in cell cycle progression and apoptosis make it an attractive target for researchers to study. Further studies are needed to determine the effectiveness of targeting MIR6890 as a drug or biomarker.
Protein Name: MicroRNA 6890
The "MIR6890 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6890 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877
